Free CME/CE Education On-Demand

Explore Our CME/CE On-Demand Lineup

Select a tile below to find out more!

Featured Activities (Bispecifics)

Bispecific Antibodies: Past, Present, and Future (Through Sep 22, 2026)

This multi-faculty CME course is the first installment in a three-part series offering an in-depth exploration of bispecific antibody therapy.

Mitigation and Management of Bispecific Antibody Toxicities in Myeloma & Lymphoma (Through Sep 22, 2026)

This multi-faculty CME course is the second installment in a three-part series offering an in-depth exploration of bispecific antibody therapy.

Effective Implementation of Bispecific Antibodies (Through Sep 22, 2026)

This multi-faculty CME course is the final installment in a three-part series offering an in-depth exploration of bispecific antibody therapy.

Free CME/CE Oncology

CATEGORY: SOLID TUMOR

Molecular Imaging for Metastatic Breast Cancer (Through Dec 1, 2026) -

Evolving Treatment Landscape in HR+/HER2- Metastatic Breast Cancer: Integrating Biomarkers and Novel Targeted Agents (Through Dec 1, 2026)

Practical Approaches to Identifying and Managing Adverse Events in HR+/HER2- Metastatic Breast Cancer (Through Dec 1, 2026)

Supportive Care in Individuals with Head & Neck Cancer (Through Jan 23, 2027)

Living With Small Cell Lung Cancer (SCLC): Current Therapies and Looking Towards the Future (Through Jan 23, 2027)

Spotlight on Desmoid Tumors: Bridging Knowledge Gaps for Optimal Patient Care (Through Feb 13, 2027)

Aligning Bladder Cancer Care with Evolving Best Practices (Through May 11, 2027)

Spotting the Unseen: Lung Cancer Screening (Through Jun 12, 2027)

Multidisciplinary Perspectives on the Management of Metastatic Colon Cancer (Through Jun 12, 2027)

Improving Outcomes in Gastric and GEJ Cancers (Through Jun 22, 2027)

Bridging the Gap in Neurofibromatosis Type 1-Plexiform Neurofibroma Care (Through Aug 31, 2027)

Creating Care Pathways for Precision Medicine in Solid Tumors: The Role of APPs in Biomarker-Driven Oncology (Through Aug 31, 2027)

CATEGORY: HEMATOLOGY

Mitigation and Management of Bispecific Antibody Toxicities in Myeloma & Lymphoma (Through Sept 22, 2026)

Managing CAR T-cell Related Toxicities: The Acute, The Subacute, and The Chronic (Through Jan 23, 2027)

Closing the Gap: Optimizing AML Treatment in Aging Adults (Through Jan 23, 2027)

Target Practice: Cellular Therapies, Side Effects, and Making Sense of the Acronyms (Through Jun 12, 2027)

Bi-Specific Antibodies Today and Tomorrow: What APPs Need to Know (Through Jun 12, 2027)

Classical Hematology: Venous Thromboembolism, Thalassemia, and Hemochromatosis (Through Jun 12, 2027)

Anemia: Rational Approach to Diagnosis and Treatment(Through Jun 12, 2027)

CATEGORY: GENERAL CANCER

Bispecific Antibodies: Past, Present, and Future (Through Sept 22, 2026)

Effective Implementation of Bispecific Antibodies (Through Sept 22, 2026)

Fe-sponse Ready: Managing IV Iron Infusions with Confidence (Through Jan 23, 2027)

Radiation Oncology: Demystifying The Magic (Through Jan 23, 2027)

Integrative Oncology: A Patient Centered and Multidisciplinary Approach to Cancer Care (A Panel Discussion) (Through Jan 23, 2027)

Fertility Preservation in Cancer Patients (Through Jan 23, 2027)

Beyond the Infusion Chair: Practical Implications of Subcutaneous Immunotherapies (Through Jan 23, 2027)

Navigating Herbal and Supplement Use in Cancer Patients (Through Jan 23, 2027)

The Psychosocial Aspects of Nursing: Emotional Intelligence, Empathy, and Burnout (Through Jun 12, 2027)

From Impact to Influence: Amplifying APP Leadership Opportunity through Self-Advocacy and Strategic Visibility (Through Jun 12, 2027)

Work Smarter Not Harder: How AI Can Improve Your Efficiency and Quality of Life as an APP (Through Jun 12, 2027)

Palliative Care in Oncology: A Partner in Patient-Centered Care (Through Jun 12, 2027)

Free CME/CE NON ONCOLOGY

Check back soon!